SEC Form D private-offering filing

Numerion Labs, Inc.

Name: Numerion Labs, Inc. - new SEC Form D private-offering filing, San Francisco, CA
Published: 2026-03-19

A new SEC Form D private-offering notice from San Francisco, CA, a $35,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Numerion Labs, Inc. site↗ Verified via SEC Form D

AI driven drug discovery company using deep learning to find novel small molecule therapeutics, with programs in immune and inflammatory disease.

Filed 2026-03-19Filed to raise $35,000,000First money in 2026-03-10Raised so far $19,794,945HQ (as filed) San Francisco, CASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified numerionlabs.ai↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.